Jim Simons Renaissance Technologies
AUM
$75.2B
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Quarter Return
+9.73%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$80.4B
AUM Growth
+$80.4B
(-13%)
Cap. Flow
-$16.1B
Cap. Flow
% of AUM
-19.99%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
3,937
New
595
Increased
1,077
Reduced
1,582
Closed
679
Top Buys
| 1 |
Tesla
TSLA
|
$378M |
| 2 |
AT&T
T
|
$328M |
| 3 |
Roku
ROKU
|
$326M |
| 4 |
Qualcomm
QCOM
|
$269M |
| 5 |
PARA
Paramount Global Class B
PARA
|
$255M |
Top Sells
| 1 |
Baidu
BIDU
|
$1.17B |
| 2 |
Bristol-Myers Squibb
BMY
|
$727M |
| 3 |
Pinduoduo
PDD
|
$599M |
| 4 |
AbbVie
ABBV
|
$564M |
| 5 |
Chipotle Mexican Grill
CMG
|
$483M |
Sector Composition
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.2% |
| 4 | Consumer Discretionary | 10.61% |
| 5 | Consumer Staples | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$250B
| $1.68B | 2.08% | 24,846,671 -1,994,500 | -7% | -$134M |
|
2
VeriSign
VRSN
$25.4B
| $968M | 1.2% | 4,868,314 -853,220 | -15% | -$170M |
|
3
Zoom
ZM
$24.4B
| $810M | 1.01% | 2,520,863 +132,329 | +6% | +$42.5M |
|
4
Monster Beverage
MNST
$60.9B
| $725M | 0.9% | 7,956,760 -2,272,900 | -22% | -$207M |
|
5
Target
TGT
$43.6B
| $710M | 0.88% | 3,586,059 -1,759,606 | -33% | -$349M |
|
6
Atlassian
TEAM
$47B
| $704M | 0.88% | 3,341,420 -1,003,600 | -23% | -$212M |
|
|
7
Baidu
BIDU
$32.7B
| $697M | 0.87% | 3,204,791 -5,385,073 | -63% | -$1.17B |
|
8
Palo Alto Networks
PANW
$127B
| $664M | 0.83% | 2,063,130 -989,599 | -32% | -$319M |
|
9
Kroger
KR
$44.5B
| $618M | 0.77% | 17,174,071 -7,473,144 | -30% | -$269M |
|
10
Franco-Nevada
FNV
$35.9B
| $606M | 0.75% | 4,837,390 -705,200 | -13% | -$88.4M |
|
11
Vodafone
VOD
$28.8B
| $595M | 0.74% | 32,310,076 -4,672,900 | -13% | -$86.1M |
|
12
Molina Healthcare
MOH
$9.7B
| $577M | 0.72% | 2,466,415 -633,950 | -20% | -$148M |
|
|
ABMD
13
DELISTED
Abiomed Inc
ABMD
| $567M | 0.71% | 1,780,123 -213,677 | -11% | -$68.1M |
|
|
14
Tesla
TSLA
$1.09T
| $553M | 0.69% | 827,381 +566,506 | +217% | +$378M |
|
15
Biogen
BIIB
$19.4B
| $542M | 0.67% | 1,938,162 -1,099,600 | -36% | -$308M |
|
16
United Therapeutics
UTHR
$13.8B
| $537M | 0.67% | 3,207,591 -399,700 | -11% | -$66.9M |
|
17
Hershey
HSY
$37B
| $532M | 0.66% | 3,361,261 -20,005 | -0.6% | -$3.16M |
|
18
Vertex Pharmaceuticals
VRTX
$101B
| $516M | 0.64% | 2,400,284 -1,175,646 | -33% | -$253M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $509M | 0.63% | 3,328,121 -785,583 | -19% | -$120M |
|
20
F5
FFIV
$17.9B
| $500M | 0.62% | 2,397,136 -621,700 | -21% | -$130M |
|
|
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $480M | 0.6% | 5,209,963 -1,589,000 | -23% | -$146M |
|
|
22
Roku
ROKU
$14.1B
| $474M | 0.59% | 1,455,700 +1,001,745 | +221% | +$326M |
|
23
Etsy
ETSY
$5.32B
| $465M | 0.58% | 2,308,208 -1,521,900 | -40% | -$307M |
|
24
Fortinet
FTNT
$60.5B
| $447M | 0.56% | 2,424,684 -1,115,800 | -32% | -$206M |
|
25
Alphabet (Google) Class A
GOOGL
$2.56T
| $442M | 0.55% | 214,348 +22,400 | +12% | +$46.2M |
|